Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
367,596,728
-
Share change
-
-1,396,236
-
Total reported value
-
$34,254,428,099
-
Put/Call ratio
-
117%
-
Price per share
-
$93.30
-
Number of holders
-
890
-
Value change
-
-$325,172,905
-
Number of buys
-
438
-
Number of sells
-
482
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2023
As of 30 Sep 2023,
DEXCOM INC - Common Stock (DXCM) was held by
890 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
367,596,728 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, Capital Research Global Investors, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Nuveen Asset Management, LLC, and Invesco Ltd..
This page lists
890
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.